Key facts
- This page summarizes Alan F. Holmer's Form 4 filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Jun 2024, 16:24.
Alan F. Holmer - 14 Jun 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)
- Reporting relationship
- Director
- Issuer ticker
- CRBP
- Reported as of
- 14 Jun 2024
- Net transaction value
- +$50,010
- SEC form
- 4
- Accepted by SEC
- 14 Jun 2024, 16:24:49 UTC
- Prior SEC filing
- 03 Jun 2024
- Next SEC filing
- 02 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Meghan Houghton, attorney-in-fact for Alan Holmer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alan F. Holmer filed Form 4 for Corbus Pharmaceuticals Holdings, Inc. (CRBP) on 14 Jun 2024.
Change
- Previous filing in this sequence was filed on 03 Jun 2024.
- Current net transaction value: +$50,010.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRBP
transaction
Common Stock, par value $0.0001 per share
Options Exercise
- Transaction value
- $50,010
- Shares
- +1,667
- Change %
- +40%
- Price
- $30.00
- Shares after
- 5,829
- Date
- 14 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRBP
transaction
Derivative
Options to purchase common stock
Options Exercise
- Transaction value
- $0
- Shares
- -1,667
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 14 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,667
- Exercise price
- $30.00
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This amount includes 2,783 unvested RSUs that were granted on May 30, 2024 and will vest 100% on the one-year anniversary from the date of grant.
Footnote F2
The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested.